Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers | Zendy

Guo Yu | Zendy; Zakir Ali | Zendy; Anam Khan | Zendy; Kalim Ullah | Zendy; Humzah Jamshaid | Zendy; Alam Zeb | Zendy; Muhammad Imran | Zendy; Sadia Sarwar | Zendy; HanGon Choi | Zendy; Fakhar ud Din | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers

Author(s) -

Guo Yu,

Zakir Ali,

Anam Khan,

Kalim Ullah,

Humzah Jamshaid,

Alam Zeb,

Muhammad Imran,

Sadia Sarwar,

HanGon Choi,

Fakhar ud Din

Publication year - 2021

Publication title -

international journal of nanomedicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.245

H-Index - 128

eISSN - 1178-2013

pISSN - 1176-9114

DOI - 10.2147/ijn.s299443

Subject(s) - in vivo , pharmacology , pharmacokinetics , miltefosine , biodistribution , chemistry , drug carrier , in vitro , drug , medicine , biochemistry , biology , immunology , microbiology and biotechnology , leishmaniasis , visceral leishmaniasis

The purpose of this study was to investigate the suitability of nanostructured lipid carriers (NLCs) loaded with miltefosine (HePC) as an anticancer drug for the treatment of breast cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research